Skip to search formSkip to main contentSkip to account menu

Abbott 77003

Known as: ABT-77003, A 77003, A77003 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

HIV Protease InhibitorsMethylurea CompoundsPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Estimates of relative binding free energies for HIV protease inhibitors using different levels of approximations.
Although the free energy perturbation approach is a rigorous method for estimating the relative binding free energy between an… 
1994
1994
A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro.
A C2 symmetry-based HIV protease inhibitor, A77003, exerts potent antiviral activity against a wide spectrum of HIV isolates in… 
1993
1993
Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease
A synthetic, symmetry-based inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, A77003, was evaluated for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)